Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
46,261,296
-
Share change
-
+9,581,094
-
Total reported value
-
$2,405,142,948
-
Put/Call ratio
-
74%
-
Price per share
-
$51.99
-
Number of holders
-
166
-
Value change
-
+$499,807,186
-
Number of buys
-
105
-
Number of sells
-
53
Institutional Holders of MYOKARDIA INC - COM (MYOK) as of Q1 2019
As of 31 Mar 2019,
MYOKARDIA INC - COM (MYOK) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,261,296 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FARALLON CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., Casdin Capital, LLC, BB BIOTECH AG, and BAKER BROS. ADVISORS LP.
This page lists
166
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.